Annual Net Income
-$75.52 M
-$24.01 M-46.61%
31 December 2023
Summary:
Aerovate Therapeutics annual net profit is currently -$75.52 million, with the most recent change of -$24.01 million (-46.61%) on 31 December 2023. During the last 3 years, it has fallen by -$65.91 million (-685.78%). AVTE annual net income is now -2167.90% below its all-time high of -$3.33 million, reached on 31 December 2019.AVTE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Income
-$16.24 M
+$8.54 M+34.46%
30 September 2024
Summary:
Aerovate Therapeutics quarterly net profit is currently -$16.24 million, with the most recent change of +$8.54 million (+34.46%) on 30 September 2024. Over the past year, it has increased by +$3.33 million (+17.00%). AVTE quarterly net income is now -1030.71% below its all-time high of -$1.44 million, reached on 01 March 2020.AVTE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Net Income
-$84.61 M
+$3.33 M+3.78%
30 September 2024
Summary:
Aerovate Therapeutics TTM net profit is currently -$84.61 million, with the most recent change of +$3.33 million (+3.78%) on 30 September 2024. Over the past year, it has dropped by -$14.48 million (-20.65%). AVTE TTM net income is now -5792.13% below its all-time high of -$1.44 million, reached on 01 March 2020.AVTE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVTE Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.6% | +17.0% | -20.6% |
| 3 y3 years | -685.8% | -162.6% | -359.7% |
| 5 y5 years | - | - | - |
AVTE Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -685.8% | at low | -162.6% | +34.5% | -359.7% | +3.8% |
| 5 y | 5 years | -2167.9% | at low | -1030.7% | +34.5% | -5792.1% | +3.8% |
| alltime | all time | -2167.9% | at low | -1030.7% | +34.5% | -5792.1% | +3.8% |
Aerovate Therapeutics Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$16.24 M(-34.5%) | -$84.61 M(-3.8%) |
| June 2024 | - | -$24.77 M(+6.9%) | -$87.94 M(+7.0%) |
| Mar 2024 | - | -$23.19 M(+13.6%) | -$82.19 M(+8.8%) |
| Dec 2023 | -$75.52 M(+46.6%) | -$20.41 M(+4.3%) | -$75.52 M(+7.7%) |
| Sept 2023 | - | -$19.56 M(+2.8%) | -$70.13 M(+9.3%) |
| June 2023 | - | -$19.02 M(+15.2%) | -$64.16 M(+12.3%) |
| Mar 2023 | - | -$16.52 M(+10.0%) | -$57.12 M(+10.9%) |
| Dec 2022 | -$51.51 M | -$15.02 M(+10.6%) | -$51.51 M(+15.2%) |
| Sept 2022 | - | -$13.59 M(+13.3%) | -$44.71 M(+19.8%) |
| June 2022 | - | -$11.99 M(+9.9%) | -$37.31 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$10.91 M(+32.7%) | -$31.09 M(+35.4%) |
| Dec 2021 | -$22.96 M(+138.9%) | -$8.22 M(+33.0%) | -$22.96 M(+24.8%) |
| Sept 2021 | - | -$6.18 M(+7.1%) | -$18.41 M(+26.7%) |
| June 2021 | - | -$5.78 M(+107.7%) | -$14.53 M(+32.6%) |
| Mar 2021 | - | -$2.78 M(-24.1%) | -$10.96 M(+14.0%) |
| Dec 2020 | -$9.61 M(+188.6%) | -$3.67 M(+58.9%) | -$9.61 M(+61.7%) |
| Sept 2020 | - | -$2.31 M(+4.8%) | -$5.95 M(+63.4%) |
| June 2020 | - | -$2.20 M(+53.3%) | -$3.64 M(+153.3%) |
| Mar 2020 | - | -$1.44 M | -$1.44 M |
| Dec 2019 | -$3.33 M | - | - |
FAQ
- What is Aerovate Therapeutics annual net profit?
- What is the all time high annual net income for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual net income year-on-year change?
- What is Aerovate Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly net income year-on-year change?
- What is Aerovate Therapeutics TTM net profit?
- What is the all time high TTM net income for Aerovate Therapeutics?
- What is Aerovate Therapeutics TTM net income year-on-year change?
What is Aerovate Therapeutics annual net profit?
The current annual net income of AVTE is -$75.52 M
What is the all time high annual net income for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual net profit is -$3.33 M
What is Aerovate Therapeutics annual net income year-on-year change?
Over the past year, AVTE annual net profit has changed by -$24.01 M (-46.61%)
What is Aerovate Therapeutics quarterly net profit?
The current quarterly net income of AVTE is -$16.24 M
What is the all time high quarterly net income for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly net profit is -$1.44 M
What is Aerovate Therapeutics quarterly net income year-on-year change?
Over the past year, AVTE quarterly net profit has changed by +$3.33 M (+17.00%)
What is Aerovate Therapeutics TTM net profit?
The current TTM net income of AVTE is -$84.61 M
What is the all time high TTM net income for Aerovate Therapeutics?
Aerovate Therapeutics all-time high TTM net profit is -$1.44 M
What is Aerovate Therapeutics TTM net income year-on-year change?
Over the past year, AVTE TTM net profit has changed by -$14.48 M (-20.65%)